Tag
Orchid Pharma Limited
4 articles
Orchid Pharma Q2 FY27 Net Profit Surges to INR28.6 Crores
Orchid Pharma reported Q2 FY27 revenue growth of 14% YoY to INR341 crores, with EBITDA surging 148% to INR52 crores.
Gross margin improved 8 percentage points to 39% due to normalized inventory, bette
Orchid Pharma Q2 FY27 Earnings Call Recording
Orchid Pharma uploaded the audio recording of its Q2 FY27 earnings call held on November 17, 2026.
The call discussed unaudited limited reviewed standalone and consolidated results for the quarter end
Orchid Pharma Q2 FY27 Net Profit Surges 148%
• Orchid Pharma reported standalone Q2 FY27 revenue of ₹341 Cr, a 14% YoY growth, with EBITDA surging 148% to ₹52 Cr.
• The company signed two key EXBLIFEP licensing deals covering Russia and 9 Latin
Orchid Pharma Q2 FY27 Net Profit Rises 444%
Orchid Pharma reported unaudited Q2 FY27 standalone net profit of ₹36.76 crore, a 444% YoY increase, on revenue of ₹341.27 crore.
The board approved financial results for Q2 and H1 FY27, incorporating